Clinical Trials

1,200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07426094 2026-02-23

PRO-BOOST-N

1,600 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT03070886 2026-01-14

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

612 enrolled

Stage I Prostate Adenocarcinoma AJCC v7

NCT03258320 2026-01-12

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

300 enrolled

Prostatic Neoplasms

NCT03701581 2025-12-17

4-aminopyridine Treatment for Nerve Injury

70 enrolled

Erectile Dysfunction, Prostatic Neoplasms

NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

83 enrolled

Prostate CA

NCT03772834 2025-10-10

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

200 enrolled

Prostatic Neoplasms

NCT07209878 2025-10-07

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07198451 2025-09-30

GEM-IR-NMIBC

320 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT07156786 2025-09-19

N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial

72 enrolled

Neoplasms, Acute Kidney Injury

NCT06124976 2025-09-15

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

70 enrolled

Urothelial Carcinoma of the Renal Pelvis and Ureter

NCT05137561 2025-08-07

PROBIOP

217 enrolled

Prostatic Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

688 enrolled

Urinary Bladder Neoplasms

NCT05920343 2025-07-10

PREVENT-GU

Classical hematologyGenitourinary

120 enrolled

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT06972511 2025-05-15

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

120 enrolled

Oligometastatic Prostate Cancer

NCT03822845 2025-04-17

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

6 enrolled 8 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03525288 2025-03-13

PSMA-PETgRT

130 enrolled

Prostatic Neoplasms

NCT06861166 2025-03-06

Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

95 enrolled

Prostate CA

NCT02984124 2025-02-18

CHART

182 enrolled

Kidney Failure, Chronic

NCT02685397 2024-12-04

PCS IX

102 enrolled

Castration-resistant Prostate Cancer Patients with Oligometastases

NCT06601205 2024-09-19

2F

125 enrolled

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia

NCT03389451 2024-07-12

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

30 enrolled 10 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05627752 2024-02-28

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

120 enrolled

Prostatic Neoplasms

NCT06282588 2024-02-28

THUNDER

493 enrolled

Prostatic Neoplasms

NCT03388346 2024-02-15

68Ga PSMA in Preprostatectomy Patients

22 enrolled 15 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04242017 2023-12-13

LOBSTER

394 enrolled

Phase 2/3 Enrolling by invitation

Prostatic Neoplasms

NCT03459820 2023-11-27

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

1,500 enrolled

Prostatic Neoplasms

NCT00584532 2023-11-24

GCP

66 enrolled

Neoplasms, Prostatic Neoplasms

NCT04654338 2023-06-27

EARTH

30 enrolled

Prostatic Neoplasms

NCT05841992 2023-05-03

Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

100 enrolled

Prostatic Neoplasms

NCT01907009 2023-04-19

MEL-CAP

Phase 2/3 Terminated

29 enrolled

Castrate Resistant Prostate Cancer

NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

122 enrolled 8 charts

Prostate Adenocarcinoma

NCT03103152 2023-03-29

PROVENT

104 enrolled 14 charts

Prostatic Neoplasms

NCT04627896 2023-02-02

Targeted Microwave Focal Therapy

11 enrolled

Prostatic Neoplasms

NCT03879122 2022-10-26

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

135 enrolled

Prostatic Neoplasms

NCT01869413 2022-10-04

TACT

354 enrolled

Urinary Bladder Neoplasms

NCT02678351 2022-03-04

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

74 enrolled 9 charts

Stage II Prostate Adenocarcinoma

NCT02673151 2022-01-13

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

61 enrolled 10 charts

BreastGastrointestinalGenitourinaryThoracic

Prostatic Neoplasms

NCT01902823 2019-12-13

Effect of Cancer Nurse Navigators on Patient Outcomes

Phase 2/3 Terminated

16 enrolled

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02759783 2019-08-21

CORE

BreastGenitourinaryThoracic

245 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT02355886 2019-06-04

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

25 enrolled 8 charts

Urinary Bladder Neoplasms

NCT01668459 2018-12-04

CabB1

20 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT01206270 2018-09-25

ALCeP

56 enrolled

Hypogonadism, Infertility, Klinefelter Syndrome, Testicular Neoplasms

NCT03427034 2018-02-09

ABSEIL

2,100 enrolled

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT01105338 2018-01-23

ProDiet

126 enrolled

Prostatic Neoplasms

NCT03344822 2017-11-17

TePSMAG-68

33 enrolled

Prostatic Neoplasms

NCT02883153 2017-06-19

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

30 enrolled

Carcinoma, Renal Cell

NCT02016040 2017-04-19

Focal Therapy Using HIFU for Localised Prostate Cancer

25 enrolled

Prostatic Neoplasms

NCT02935972 2017-01-23

Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy

336 enrolled